Fesoterodine (Toviaz) for Overactive Bladder
The FDA has approved the marketing of fesoterodine (Toviaz - Pfizer), a muscarinic receptor antagonist, for treatment of overactive bladder. It is the sixth antimuscarinic drug approved for this indication....
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Fesoterodine (Toviaz) for Overactive Bladder
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1311
Article Code: 1311b
Date: May 4, 2009
Volume: 51
Pages: 34-35
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 1311
Article Code: 1311b
Date: May 4, 2009
Volume: 51
Pages: 34-35
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)